Etiometry Co-Authors Award-Winning PCICS Abstract
News and Press Releases
Receives a Prestigious “Top Abstract” Award at the Pediatric Cardiac Intensive Care Society (PCICS) International Meeting
Miami, December 12, 2016—Etiometry, a pioneering leader in next-generation patient monitoring, received a “Top Abstract” award at the PCICS International Meeting for, “Using a High-Fidelity Physiologic Monitoring System to Evaluate a Clinical Protocol for Post-Operative Single Ventricle Congenital Heart Disease.”
The abstract illustrates the tremendous value that high-fidelity data capture brings to the evaluation of the effectiveness of clinical guidelines. It summarizes the results of a joint study between a major Boston pediatric hospital and Etiometry that evaluated the use of the FDA-cleared Etiometry T3 Visualization & Data Aggregation Software to track and record a patient’s physiological state for the purpose of assessing compliance to a clinical protocol as it relates to outcomes.
According to Etiometry COO Evan Butler, “This work demonstrates that the high-frequency, high-fidelity data capture in our T3 Software allows for novel analysis of clinical protocols. It shows how the Etiometry Platform provides unique insight into the effect of guidelines on clinical practice by capturing objective and clear evidence of how patient management is affected by introducing a new standard of care.”
The lead author was Dr. Michael Goldsmith, a pediatric cardiology Fellow at Boston Children’s Hospital, and it was co-authored by Boston Children’s Hospital Pediatric Cardiac Intensivists Dr. Joshua Salvin and Dr. John Kheir and Etiometry’s COO Evan Butler and CTO Dimitar Baronov, PhD.About PCICS
The Pediatric Cardiac Intensive Care Society (PCICS) promotes excellence in pediatric cardiac care medicine. For more information, visit www.pcics.org.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking
BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification […]
Boston Children’s enhances care with clinical intelligence platform
At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]